“Our experience with FDA-approved guidelines for visual interpretation of 18F-flortaucipir PET for Alzheimer disease”
Hosted by the Charles F. and Joanne Knight Alzheimer’s Disease Research Center (Knight ADRC)
Full schedule, Knight ADRC seminars
For inquiries contact Alicia Larson.
![](https://neuroscienceresearch.wustl.edu/files/2023/04/4-25-2023_KnightADRCSeminar.png)